In what it called a “historic” move, the World Health Organization is recommending widespread use of the world’s first and only malaria vaccine among children in sub-Saharan Africa and other regions where there are moderate to high levels of malaria transmission. GSK, which helped develop the vaccine, hailed the news.
Read More
Boragen, a boron-based discovery platform company based in the Research Triangle Park, has won a $300,500 Phase I Small Business Innovation Research grant for research on controlling malaria. Here are the details.
Read More
The volcanic glass material used in this new intervention is perlite, an industrial mineral most frequently used in building materials and in gardens as a soil additive.
Read More
Researchers have developed a new weapon in the fight against malaria — a fungus genetically engineered using a gene found in the venom of an Australian spider.
Read More
Mosquitoes won’t fly anywhere near the sweet wormwood herb (Artemisia annua), so it makes perfect sense that a chemical compound produced by the plant has become the first line of treatment against malaria. NCSU says more of the compound can be produced.
Read More
Some 360,000 children a year in three African countries will receive the world’s first malaria vaccine as part of a large-scale pilot project, the World Health Organization says. The vaccine was developed by GlaxoSmithKline.
Read More
Researchers from North Carolina State University and the U.S. Centers for Disease Control and Prevention have come up with a technique that actually measures how much insecticide is found on the surface of mosquito nets, paving the way for efforts to determine how long the nets are effective.
Read More
